Invus Global Management, LLC - 31 Dec 2023 SCHEDULE 13G Report for Nanobiotix S.A. Ordinary shares, nominal value Euro 0.03 per share (NBTX)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Invus Public Equities, L.P.
Security
Nanobiotix S.A. Ordinary shares, nominal value Euro 0.03 per share
Symbol
NBTX
Shares outstanding
47,559,876 shares
Disclosed Ownership
4,232,829 shares
Ownership
8.9%
Form type
SCHEDULE 13G
Filing time
17 Apr 2025, 16:30:26 UTC
Date of event
31 Dec 2023
SEC
View on sec.gov

Quoteable Key Fact

"Invus Global Management, LLC disclosed 8.9% ownership in Nanobiotix S.A. Ordinary shares, nominal value Euro 0.03 per share (NBTX) on 31 Dec 2023."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13G for Nanobiotix S.A. Ordinary shares, nominal value Euro 0.03 per share (NBTX).
  • Disclosed ownership: 8.9%.
  • Date of event: 31 Dec 2023.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Apr 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.9% 4,232,829 4,232,829 0 /s/ Raymond Debbane Raymond Debbane, President, Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.9% 4,232,829 4,232,829 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.9% 4,232,829 4,232,829 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.9% 4,232,829 4,232,829 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 8.9% 4,232,829 4,232,829 0 /s/ Raymond Debbane Raymond Debbane
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .